FDA Investigator

Elaine E Gilfillan

Latest inspection on record: New Brunswick, United States, March 2023 · records back to 2022

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 7 inspections across 7 sites are on record.
  • 1 Form 483 observation is attributed to this investigator.
  • Most recent recorded activity is 2023-03-24.

At a glance

Inspections

7

Sites

7

Observations

1

Career since

Mar 2022

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP.24 Mar 2023Human DrugsOn file
CHARLES RIVER LABORATORIES9 Nov 2022Human Drugs
New Dawn Manufacturing29 Aug 2022Human Drugs
Frontage Laboratories, Inc.11 Aug 2022Human DrugsOn file
EMS Acquisition Corp22 Jul 2022Human DrugsView 483 →

Sites inspected

CHARLES RIVER LABORATORIESWayne, United States1 insp.
New Dawn ManufacturingUpper Marlboro, United States1 insp.
Frontage Laboratories, Inc.Exton, United States1 insp.
EMS Acquisition CorpMorgantown, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Elaine E Gilfillan's 1 observation

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site